Philippi Prietocarrizosa Ferrero DU & Uría Chile has represented Fresenius Medical Care in the sale of part of its Chilean subsidiaries to DaVita. This was part of a larger sale of several of Fresenius
Tags :Ecuador
Carey has acted as Chilean advisor to Graham Partners, a private equity firm that invests in technology companies, through its US subsidiary OptConnect, in the acquisition of M2M Data Global, a Chilean company dedicated
Flor Bustamante Pizarro & Hurtado has announced the appointment of Alejandro Pérez Arellano (pictured) as the firm’s newest partner, making him the youngest partner in FBPH’s history. Alejandro has extensive experience in
Flor Bustamante Pizarro & Hurtado has announced the incorporation of Mauricio Bustamante Holguín (pictured), from Bustamante Holguín Abogados, as a new partner of the firm to lead the Real Estate Department. Mauricio holds
Clifford Chance has advised Corporación Andina de Fomento (CAF) as lender in connection with the A/B loan granted to the Ecuadorian bank Banco Guayaquil. The loan proceeds will support environmentally sustainable, women-led micro,
Dentons Paz Horowitz has acted in the acquisition of Cinemark’s local operations in Ecuador by the Ecuadorian cinema chain Multicines. The transaction closed on 6 November, making Multicines the sole shareholder of Cinemark’s Ecuadorian
Dentons Paz Horowitz has announced the promotion of Agustín Acosta Cárdenas (pictured top) as managing partner of the office, by unanimous decision of all partners of the firm. Agustín has more than 14
Clifford Chance has advised Banco General and Citigroup Global Markets, as joint bookrunners and lenders, in connection with a USD $385 million senior secured syndicated loan to Grupo Unicomer. The company will use the proceeds to
Flor Bustamante Pizarro & Hurtado has advised Empresa Operadora Metro de Medellín-Transdev EOMMT in the renegotiation process of the Quito Metro Operation Contract with Empresa Pública del Municipio de Quito (EPMMQ). This operation
Carey has locally represented Viatris in the sale of marketing and intellectual property rights to a portfolio of well-known branded products in Latin America, such as Lipitor, Viagra, Lyrica, Zoloft, Norvasc and Celebrex, to South
